[Update in treatment of psoriatic arthritis]
Tunisie Medicale [La]. 2008; 86 (12): 1036-1041
em Francês
| IMEMR
| ID: emr-119712
ABSTRACT
Psoriatic arthritis is a chronic rheumatic disease making part of spondylarthropathies. It is the most frequent chronic inflammatory rheumatism after rheumatoid arthritis. Eventhough, it is usually a benign affection, it may be destructive leading to handicap. Several new medications have been introduced, including anti-tumor necrosis factor [TNF alpha blockers] and leflunomide for treatment of psoriatic arthritis. Many studies show the efficacy of these medications in this disease
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Fator de Necrose Tumoral alfa
/
Isoxazóis
/
Anticorpos Monoclonais
Limite:
Humanos
Idioma:
Francês
Revista:
Tunisie Med.
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS